Senior Director, HEOR – Acoramidis (Global Lead)
Quick Summary
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research…
Global HEOR Strategy: Define and lead the end-to-end global HEOR strategy for acoramidis across launch and lifecycle, ensuring alignment with clinical, regulatory, and commercial objectives and driving evidence-based decision-making Evidence…
Advanced degree (PhD, PharmD, MPH, MD, or equivalent) in health economics, outcomes research, epidemiology, or related field 10+ years of progressive HEOR experience within biopharma or consulting, including leadership of global programs…
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
What You'll Do
BridgeBio is seeking a highly strategic and execution-oriented HEOR leader to define and drive the global evidence strategy for acoramidis in ATTR-CM. This individual will play a pivotal role in enabling successful global launch, optimizing payer access, and sustaining long-term product differentiation in an increasingly competitive and evolving landscape.
As the global HEOR lead, this role will shape the evidence generation agenda across the product lifecycle—spanning clinical development, launch, and post-marketing—leveraging real-world evidence (RWE), comparative effectiveness research, and patient-centered outcomes. The leader will serve as a key partner to Market Access, Medical Affairs, Clinical Development, and Commercial teams to ensure evidence translates into impactful value narratives for payers and HTA bodies worldwide.
Why This Role Matters
Acoramidis represents a transformative opportunity in ATTR-CM. This role is central to articulating and proving its value to patients, providers, and payers globally. By shaping the evidence strategy and driving impactful insights, this leader will directly influence access, adoption, and long-term success in a competitive and rapidly evolving therapeutic area.
Key Responsibilities
Requirements
~1 min read-
Strategic, enterprise-level thinker with strong business acumen
-
Ability to translate complex evidence into clear, compelling value narratives for diverse stakeholders
-
Influential cross-functional leader with a collaborative and proactive mindset
-
Strong project leadership and ability to manage multiple priorities in a fast-paced environment
-
Executive presence with excellent communication and stakeholder engagement skills
#LI-LN1
What We Offer
~1 min readLocation & Eligibility
Listing Details
- Posted
- April 23, 2026
- First seen
- April 23, 2026
- Last seen
- May 6, 2026
Posting Health
- Days active
- 12
- Repost count
- 0
- Trust Level
- 47%
- Scored at
- May 6, 2026
Signal breakdown
Please let Bridgebio know you found this job on Jobera.
4 other jobs at Bridgebio
View all →Explore open roles at Bridgebio.
Browse Similar Jobs
Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
No spam. Unsubscribe at any time.
